000 | 01974 a2200565 4500 | ||
---|---|---|---|
005 | 20250515224757.0 | ||
264 | 0 | _c20100903 | |
008 | 201009s 0 0 eng d | ||
022 | _a1932-8737 | ||
024 | 7 |
_a10.1002/clc.20775 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSchoenenberger, Andreas W | |
245 | 0 | 0 |
_aProgression of coronary artery disease during long-term follow-up of the Swiss Interventional Study on Silent Ischemia Type II (SWISSI II). _h[electronic resource] |
260 |
_bClinical cardiology _cMay 2010 |
||
300 |
_a289-95 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAngioplasty, Balloon, Coronary |
650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
650 | 0 | 4 |
_aCardiovascular Agents _xtherapeutic use |
650 | 0 | 4 | _aChi-Square Distribution |
650 | 0 | 4 | _aCoronary Angiography |
650 | 0 | 4 |
_aCoronary Stenosis _xdiagnostic imaging |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
650 | 0 | 4 |
_aHypolipidemic Agents _xtherapeutic use |
650 | 0 | 4 | _aLogistic Models |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMyocardial Infarction _xdiagnostic imaging |
650 | 0 | 4 |
_aMyocardial Ischemia _xdiagnostic imaging |
650 | 0 | 4 | _aOdds Ratio |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aSmoking Cessation |
650 | 0 | 4 | _aSwitzerland |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aJamshidi, Peiman | |
700 | 1 | _aKobza, Richard | |
700 | 1 | _aZuber, Michel | |
700 | 1 | _aStuck, Andreas E | |
700 | 1 | _aPfisterer, Matthias | |
700 | 1 | _aErne, Paul | |
773 | 0 |
_tClinical cardiology _gvol. 33 _gno. 5 _gp. 289-95 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/clc.20775 _zAvailable from publisher's website |
999 |
_c19864910 _d19864910 |